13. ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)

12 Months Ended

Aug. 31, 2017

Schedule of statement of income

	For the fiscal year ended August 31 (in 1000’s)
	(Pro forma)*		(Pro forma)
	2017		2016
Net Sales	$	27,184	$	22,847
Net Income	$	6,325	$	5,423

Cognigen

Allocation of purchase price

Assets acquired, including accounts receivable of $934,000 and estimated Contracts receivable of $398,000	$	1,524,389
Fixed assets acquired		458,351
Estimated value of software acquired		200,000
Estimated value of Intangibles acquired (Customer Lists, trade name etc.)		1,600,000
Working Capital Adjustment		(26,707	)
Current Liabilities assumed		(644,499	)
Goodwill		4,789,248
Estimated Deferred income taxes		(662,500	)
Total Consideration	$	7,238,282

DILIsym

Allocation of purchase price

Assets acquired, including accounts receivable of $255,000 and estimated Contracts receivable of $153,000	$	2,283,110
Developed Technologies Acquired		2,850,000
Estimated value of Intangibles acquired (Customer Lists, trade name etc.)		2,840,000
Current Liabilities assumed		(911,049	)
Goodwill		5,597,950
Estimated Deferred income taxes		(2,212,160	)
Total Consideration	$	10,463,310